NGeneBio proudly participated in MEDICA 2022, the world's largest medical equipment exhibition, which took place in Dusseldorf, Germany from November 14 to November 17, 2022.

At this exhibition, NGeneBio showcased an extensive range of precision diagnostic products, including the solid cancer precision diagnostic product ONCOaccuPanel™ and SOLIDaccuTest™. Additionally, they presented the blood cancer precision diagnostic product HEMEaccuTest™, tissue compatibility antigen precision diagnostic product HLAaccuTest™, precision diagnostic products for breast cancer and ovarian cancer, known as BRCAaccuTest™, tuberculosis precision diagnostic product MTBaccuPanel™, and cutting-edge disease genomics analysis software.

Furthermore, in their quest to expand their footprint in the European NGS-based precision diagnostic service market, NGeneBio actively engaged in discussions about sales strategies and partnerships in response to the evolving market landscape. This strategic focus, particularly in Europe, centers on NGS clinical testing services and collaboration with sales representatives in key European regions and distributors. Their ambitious plans aim to extend their presence in the European and North African markets.

* For detailed information about MEDICA 2022, please visit www.medica-tradefair.com